-+ 0.00%
-+ 0.00%
-+ 0.00%
BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions
Share
Listen to the news

NEW YORK, Aug. 24, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) ("BrainStorm" or the "Company"), a developer of cell therapies for neurodegenerative diseases, today announced that members of its executive leadership team, including President and Chief Executive Officer Chaim Lebovits and Executive Chairman Peter J. Pitts, will participate in the 31st edition of the Dubai International Pharmaceuticals & Technologies Conference and Exhibition (DUPHAT), to be held August 25 to 27, 2026, at the Dubai World Trade Centre in Dubai, UAE.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending